Company
Intellia Therapeutics, Inc.
NTLA · CIK 0001652130
Sale of 1,864 shares at $12.43 per share.
Reporting Person Dube Michael P · Officer Title VP, Chief Accounting Officer · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001193125-26-415541 · filed 2026-10-06 · View filing →
Sale of 2,785 shares at $13.00 per share.
Reporting Person LEONARD JOHN M · Officer Title President and CEO · Transaction Code S
Traded Aug 21, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363567 · filed 2026-08-24 · View filing →
Sale of 19,890 shares at $12.60 per share.
Reporting Person LEONARD JOHN M · Officer Title President and CEO · Transaction Code S
Traded Aug 20, 2026 · Disclosed Aug 24, 2026
Source: SEC Form 4 · 0001193125-26-363567 · filed 2026-08-24 · View filing →